The stock of Alder Biopharmaceuticals Incorporated (NASDAQ:ALDR) registered an increase of 0.53% in short interest. ALDR’s total short interest was 4.87M shares in February as published by FINRA. Its up 0.53% from 4.84 million shares, reported previously. With 727,200 shares average volume, it will take short sellers 7 days to cover their ALDR’s short positions. The short interest to Alder Biopharmaceuticals Incorporated’s float is 13.37%. The stock decreased 2.03% or $0.44 during the last trading session, hitting $21.23. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has declined 57.43% since July 15, 2015 and is downtrending. It has underperformed by 48.43% the S&P500.
Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $893.31 million. The Firm discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. It currently has negative earnings. The Firm has developed an antibody platform designed to select antibodies that have the potential to maximize efficacy, as well as speed of onset and durability of therapeutic response.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
